Identification of specific metabolites in culture supernatant of Mycobacterium tuberculosis using metabolomics: exploration of potential biomarkers

• Published in: Emerging microbes & infections 2015-01, Vol.4 (1), p.1-10
• Main Authors: Lau, Susanna KP, Lam, Ching-Wan, Curreem, Shirly OT, Lee, Kim-Chung, Lau, Candy CY, Chow, Wang-Ngai, Ngan, Antonio HY, To, Kelvin KW, Chan, Jasper FW, Hung, Ivan FN, Yam, Wing-Cheong, Yuen, Kwok-Yung, Woo, Patrick CY
• Format: Article
• Language: English
• Subjects: Biomarkers; Biomarkers - analysis; Chromatography, High Pressure Liquid; diagnosis; Humans; Ions; Lipids - analysis; Mass spectrometry; Metabolites; Metabolomics; Mycobacterium tuberculosis; Mycobacterium tuberculosis - classification; Mycobacterium tuberculosis - isolation & purification; Mycobacterium tuberculosis - metabolism; Nontuberculous Mycobacteria - classification; Nontuberculous Mycobacteria - isolation & purification; Nontuberculous Mycobacteria - metabolism; Original; Pantothenic Acid - analogs & derivatives; Pantothenic Acid - analysis; Principal components analysis; Scientific imaging; specific; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tuberculosis
• ISSN: 2222-1751; 2222-1751
• DOI: 10.1038/emi.2015.6

Although previous studies have reported the use of metabolomics for Mycobacterium species differentiation, little is known about the potential of extracellular metabolites of Mycobacterium tuberculosis (MTB) as specific biomarkers. Using an optimized ultrahigh performance liquid chromatography-electrospray ionization-quadruple time of flight-mass spectrometry (UHPLC-ESI-Q-TOF-MS) platform, we characterized the extracellular metabolomes of culture supernatant of nine MTB strains and nine non-tuberculous Mycobacterium (NTM) strains (four M. avium complex, one M. bovis Bacillus Calmette-Guérin (BCG), one M. chelonae, one M. fortuitum and two M. kansasii). Principal component analysis readily distinguished the metabolomes between MTB and NTM. Using multivariate and univariate analysis, 24 metabolites with significantly higher levels in MTB were identified. While seven metabolites were identified by tandem mass spectrometry (MS/MS), the other 17 metabolites were unidentified by MS/MS against database matching, suggesting that they may be potentially novel compounds. One metabolite was identified as dexpanthenol, the alcohol analog of pantothenic acid (vitamin B5), which was not known to be produced by bacteria previously. Four metabolites were identified as 1-tuberculosinyladenosine (1-TbAd), a product of the virulence-associated enzyme Rv3378c, and three previously undescribed derivatives of 1-TbAd. Two derivatives differ from 1-TbAd by the ribose group of the nucleoside while the other likely differs by the base. The remaining two metabolites were identified as a tetrapeptide, Val-His-Glu-His, and a monoacylglycerophosphoglycerol, phosphatidylglycerol (PG) (16∶0/0∶0), respectively. Further studies on the chemical structure and biosynthetic pathway of these MTB-specific metabolites would help understand their biological functions. Studies on clinical samples from tuberculosis patients are required to explore for their potential role as diagnostic biomarkers.